Genetic Engineering and Biotechnology News interviwed Howard McLeod, PharmD, about the role of physicians and insurance companies in gauging chemotherapy dosages in an article titled
“Chemotherapy for the 21st Century” published Oct. 31, 2012.
Dr. McLeod is a Fred Eshelman Distinguished Professor in the division of Pharmacotherapy and Experimental Therapeutics at UNC. He is a member of UNC Lineberger.
The article can be read here: www.genengnews.com/keywordsandtools/print/3/29294/